Metyra 50 is an injectable formulation of Methotrexate IP (50 mg/2 ml), which acts as both a chemotherapy agent and an immunosuppressant. It belongs to a class of medications called antimetabolites.
Relitest-P is a brand name for an injectable medication containing 100 mg/ml of Testosterone Propionate USP, typically manufactured by RA Pharma. It is a fast-acting synthetic androgen and anabolic steroid (AAS) primarily used for Testosterone Replacement Therapy (TRT).